Neurofibromatosis type 1 (NF1) is a genetic disorder that affects around 1:3000 live births. While the disease has nearly 100% penetrance in patients, NF1 has a diverse spectrum of manifestations. Hallmark traits of the disease include caf-au-lait macules, cutaneous neurofibromas (cNF), plexiform neurofibromas (pNF) and malignant peripheral nerve sheath tumors (MPNST), among other symptoms. In NF1 patients, cNFs usually arise at puberty and beyond, can range widely in size and number, and can cause itching, pain, superficial infections as well as psychosocial and cosmetic burdens. Currently, there is no approved therapeutic option for cNFs aside from elective surgery. The development of new therapeutic approaches for cNF will require an understanding of the cNF cellular origin that can be used to elucidate mechanisms that underpin cNF formation and growth. While biallelic inactivation of NF1 in neoplastic Schwann cells is essential for cNF formation, it is not sufficient, pointing to the critical roles of other genetic or epigenetic changes as well as extrinsic signals from other cell types in the tumor microenvironment. While the field has made significant inroads towards our understanding of these tumors, there are still gaps in our knowledge of cNF pathogenesis that could be addressed by the adoption of a systemic approach to decipher all the biological steps in cNF development from the cell of origin to tumor stage to identify the ?rate limiting step? that can be therapeutically targeted to prevent or delay cNF formation. Therefore, in this application, we propose a set specific aims to fill this knowledge gap: We will define the identity of the cNF cell of origin in mice that will guide us to identify the cells of origin for human cNF. We will next decipher how the cell of origin and the tumor microenvironment contribute to drive cNF initiation that will uncover its pathogenesis to delineate biological steps and mechanisms in tumor development as well as generating of preclinical models system that elucidate cNF biology and enable preclinical therapeutic testing.

Public Health Relevance

Neurofibromas develop from a type of cell called Schwann cells which normally produce the insulating myelin sheath covering peripheral nerves. Neurofibroma can infiltrate the nerves; splay apart the individual nerve fibers and can damage their function. Patients with Neurofibroma suffer from chronic pain, numbness, and their physical impairment of vital organ or neural function can be life threatening. However, little is known about the mechanisms mediating the initiation and progression of these tumors and there is no effective medical treatment exists currently. This research proposal will fill this gap of knowledge to identify the cell of origin for these tumors to elucidate the mechanisms by which the cell of origin and the tumor microenvironment contribute to drive Neurofibroma formation, as well as to generate potential specific therapeutic targets for Neurofibroma.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA166593-06A1
Application #
9593214
Study Section
Arthritis, Connective Tissue and Skin Study Section (ACTS)
Program Officer
Hildesheim, Jeffrey
Project Start
2012-08-03
Project End
2023-07-31
Budget Start
2018-08-03
Budget End
2019-07-31
Support Year
6
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Dermatology
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Allaway, Robert J; Gosline, Sara J C; La Rosa, Salvatore et al. (2018) Cutaneous neurofibromas in the genomics era: current understanding and open questions. Br J Cancer 118:1539-1548
Chen, Zhiguo; Mo, Juan; Brosseau, Jean-Philippe et al. (2018) Spatiotemporal Loss of NF1 in Schwann Cell Lineage Leads to Different Types of Cutaneous Neurofibroma Susceptible to Modification by the Hippo Pathway. Cancer Discov :
Brosseau, Jean-Philippe; Liao, Chung-Ping; Wang, Yong et al. (2018) NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. Nat Commun 9:5014
Brosseau, Jean-Philippe; Pichard, Dominique C; Legius, Eric H et al. (2018) The biology of cutaneous neurofibromas: Consensus recommendations for setting research priorities. Neurology 91:S14-S20
Liao, Chung-Ping; Booker, Reid C; Brosseau, Jean-Philippe et al. (2018) Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis. J Clin Invest 128:2848-2861
Liao, Chung-Ping; Booker, Reid C; Morrison, Sean J et al. (2017) Identification of hair shaft progenitors that create a niche for hair pigmentation. Genes Dev 31:744-756
Liao, Chung-Ping; Pradhan, Sanjay; Chen, Zhiguo et al. (2016) The role of nerve microenvironment for neurofibroma development. Oncotarget 7:61500-61508
Chau, Vincent; Lim, S Kyun; Mo, Wei et al. (2014) Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors. Cancer Res 74:586-97
Patel, Amish J; Liao, Chung-Ping; Chen, Zhiguo et al. (2014) BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction. Cell Rep 6:81-92
Chen, Zhiguo; Liu, Chiachi; Patel, Amish J et al. (2014) Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma. Cancer Cell 26:695-706

Showing the most recent 10 out of 12 publications